Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Publications & Presentations

<< 1 2 3 4 5 6 > >>
    11. Dickson M C, Nguyen M M, Skrepnek G H. Medicaid Value-Based Contract (VBC) in the prevention of migraine. Oklahoma Health Care Authority. 2022

    12. Thompson T C, Skrepnek G H. OHCA Medication Therapy Management Program Cost Assessment. 2022

    13. Tidmore L, Keast S, Waters H, Pareja K, Cothran T, Skrepnek G H. Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia. Current Medical Research and Opinion. 2022; 38 : 1621-30

    14. Tidmore L M, Skrepnek G H. A National Assessment of Alzheimer’s Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings. Alzheimer's Disease and Associated Disorders. 2022; 36 : 230-7

    15. Boylan P, Skrepnek G, Neely S. Abstract 40: Use of standardized patients in a third-year pharmacy student capstone course to identify medication therapy problems in an objective structured clinical exam. Journal of the American College of Clinical Pharmacy. 2022; 5 : 746

<< 1 2 3 4 5 6 > >>



Grants

<< 1 2 3 4 >>
    6. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.

    7. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.

    8. C2015602 - 1815 Medication Therapy Management, Tele-MTM. Non-federal. Start Date: 2019. End Date: 2020.

    9. C7069901 - MTM Drug Utilization Review. Non-federal. Start Date: 2019. End Date: 2020.

    10. C7070101 - Study of Oklahoma Medicaid Assessing Outcomes Associated with Long-Acting Injectable Antipsychotics. Non-federal. Start Date: 2019. End Date: 2020.

<< 1 2 3 4 >>



Awards and Honors


no results

Education


no results